loadpatents
name:-0.072434902191162
name:-0.047538042068481
name:-0.0078210830688477
Pepinsky; R. Blake Patent Filings

Pepinsky; R. Blake

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pepinsky; R. Blake.The latest application filed is for "humanized and stabilized fc5 variants for enhancement of blood brain barrier transport".

Company Profile
7.57.67
  • Pepinsky; R. Blake - Arlington MA
  • Pepinsky; R. Blake - Arlilngton MA
  • Pepinsky; R. Blake - Watertown MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Humanized And Stabilized Fc5 Variants For Enhancement Of Blood Brain Barrier Transport
App 20220089704 - Smith; Benjamin A. ;   et al.
2022-03-24
SP35 Antibodies And Uses Thereof
App 20210395360 - Mi; Sha ;   et al.
2021-12-23
SP35 Antibodies And Uses Thereof
App 20200317775 - Mi; Sha ;   et al.
2020-10-08
Use Of Lingo-4 Antagonists In The Treatment Of Conditions Involving Demyelination
App 20200297800 - Mi; Sha ;   et al.
2020-09-24
Dkk2 Cysteine Rich Domain 2 Containing Proteins And Uses Thereof
App 20200270335 - Pepinsky; R. Blake ;   et al.
2020-08-27
Stabilized Proteolytically Activated Growth Differentiation Factor 11
App 20200031895 - Pepinsky; R. Blake ;   et al.
2020-01-30
Lingo-2 Antagonists For Treatment Of Conditions Involving Motor Neurons
App 20190359706 - Mi; Sha ;   et al.
2019-11-28
Methods of preventing and removing trisulfide bonds
Grant 10,308,706 - Evans , et al.
2019-06-04
SP35 Antibodies And Uses Thereof
App 20190161546 - Mi; Sha ;   et al.
2019-05-30
Use Of Lingo-4 Antagonists In The Treatment Of Conditions Involving Demyelination
App 20190060398 - Mi; Sha ;   et al.
2019-02-28
Lingo-2 Antagonists For Treatment Of Conditions Involving Motor Neurons
App 20180111994 - Mi; Sha ;   et al.
2018-04-26
LINGO-2 antagonists for treatment of conditions involving motor neurons
Grant 9,796,780 - Mi , et al. October 24, 2
2017-10-24
Compositions comprising antibodies to LINGO or fragments thereof
Grant 9,745,375 - Mi , et al. August 29, 2
2017-08-29
SP35 Antibodies And Uses Thereof
App 20170037126 - Mi; Sha ;   et al.
2017-02-09
Compositions Comprising Antibodies to Lingo or Fragments Thereof
App 20160368984 - Mi; Sha ;   et al.
2016-12-22
Use Of Lingo-4 Antagonists In The Treatment Of Conditions Involving Demyelination
App 20160213745 - Mi; Sha ;   et al.
2016-07-28
NOGO Receptor Antagonists
App 20160159878 - Lee; Daniel H.S. ;   et al.
2016-06-09
Compositions Comprising Antibodies to Lingo or Fragments Thereof
App 20160083468 - Mi; Sha ;   et al.
2016-03-24
Treatment Of Conditions Involving Demyelination
App 20160002329 - Mi; Sha ;   et al.
2016-01-07
Nogo receptor antagonists and methods of increasing neurite outgrowth
Grant 9,228,015 - Lee , et al. January 5, 2
2016-01-05
SP35 Antibodies And Uses Thereof
App 20150315273 - Mi; Sha ;   et al.
2015-11-05
Methods of Preventing and Removing Trisulfide Bonds
App 20150274808 - Evans; David ;   et al.
2015-10-01
Use of DR6 and p75 Antagonists to Promote Survival of Cells of the Nervous System
App 20150203585 - MI; Sha ;   et al.
2015-07-23
Screening methods for identifying Sp35 antagonists
Grant 9,068,992 - Mi , et al. June 30, 2
2015-06-30
Sp35 antibodies and uses thereof
Grant 9,066,984 - Mi , et al. June 30, 2
2015-06-30
Nogo Receptor Binding Protein
App 20150177240 - Mi; Sha ;   et al.
2015-06-25
Lingo-2 Antagonists For Treatment Of Conditions Involving Motor Neurons
App 20150118241 - Mi; Sha ;   et al.
2015-04-30
Methods of preventing and removing trisulfide bonds
Grant 9,005,926 - Evans , et al. April 14, 2
2015-04-14
Refolding transforming growth factor beta family proteins
Grant 8,969,042 - Rossomando , et al. March 3, 2
2015-03-03
NOGO receptor binding protein
Grant 8,932,821 - Mi , et al. January 13, 2
2015-01-13
Use of DR6 and p75 antagonists to promote survival of cells of the nervous system
Grant 8,894,999 - Mi , et al. November 25, 2
2014-11-25
Refolding Transforming Growth Factor Beta Family Proteins
App 20140322752 - Rossomando; Anthony ;   et al.
2014-10-30
NOGO Receptor Antagonists
App 20140227266 - Lee; Daniel H.S. ;   et al.
2014-08-14
Sp35 Antibodies and Uses Thereof
App 20140199315 - MI; Sha ;   et al.
2014-07-17
NOGO receptor binding protein
Grant 8,765,662 - Mi , et al. July 1, 2
2014-07-01
Refolding transforming growth factor beta family proteins
Grant 8,722,862 - Rossomando , et al. May 13, 2
2014-05-13
Nogo receptor antagonists
Grant 8,669,345 - Lee , et al. March 11, 2
2014-03-11
Polymer-conjugated glycosylated neublastin
Grant 8,642,732 - Sah , et al. February 4, 2
2014-02-04
Use of DR6 and p75 Antagonists to Promote Survival of Cells of the Nervous System
App 20140010826 - MI; Sha ;   et al.
2014-01-09
Sp35 Antibodies and Uses Thereof
App 20130336991 - MI; Sha ;   et al.
2013-12-19
Sp35 antibodies and uses thereof
Grant 8,609,407 - Mi , et al. December 17, 2
2013-12-17
Composition Comprising Antibodies to LINGO or Fragments Thereof
App 20130323786 - MI; Sha ;   et al.
2013-12-05
NOGO Receptor Binding Protein
App 20130287693 - MI; SHA ;   et al.
2013-10-31
Sp35 Antibodies and Uses Thereof
App 20130287796 - MI; Sha ;   et al.
2013-10-31
Treatment of Conditions Involving Demyelination
App 20130273558 - MI; Sha ;   et al.
2013-10-17
SP35 antibodies and uses thereof
Grant 8,551,476 - Mi , et al. October 8, 2
2013-10-08
Polyalkylene polymer compounds and uses thereof
Grant 8,524,660 - Lin , et al. September 3, 2
2013-09-03
Use of DR6 and p75 antagonists to promote survival of cells of the nervous system
Grant 8,501,178 - Mi , et al. August 6, 2
2013-08-06
Treatment of conditions involving demyelination
Grant 8,486,893 - Mi , et al. July 16, 2
2013-07-16
Composition comprising antibodies to LINGO or fragments thereof
Grant 8,425,910 - Mi , et al. April 23, 2
2013-04-23
Neublastin Variants
App 20130096065 - Rossomando; Anthony ;   et al.
2013-04-18
Functional antagonists of hedgehog activity
Grant 8,410,061 - Williams , et al. April 2, 2
2013-04-02
Polymer-conjugated Glycosylated Neublastin
App 20120316109 - Sah; Dinah Wen-Yee ;   et al.
2012-12-13
Methods of Preventing and Removing Trisulfide Bonds
App 20120264916 - Evans; David ;   et al.
2012-10-18
NOGO Receptor Binding Protein
App 20120230979 - MI; Sha ;   et al.
2012-09-13
Neublastin variants
Grant 8,263,553 - Rossomando , et al. September 11, 2
2012-09-11
Sp35 Antibodies and Uses Thereof
App 20120190070 - MI; Sha ;   et al.
2012-07-26
Use of DR6 and p75 Antagonists to Promote Survival of Cells of the Nervous System
App 20120141456 - Mi; Sha ;   et al.
2012-06-07
Polymer conjugated glycosylated neublastin
Grant 8,163,875 - Sah , et al. April 24, 2
2012-04-24
Nogo receptor binding protein
Grant 8,153,580 - Mi , et al. April 10, 2
2012-04-10
Sp35 antibodies and uses thereof
Grant 8,128,926 - Mi , et al. March 6, 2
2012-03-06
Polymer conjugates of mutated neublastin
Grant 8,119,114 - Sah , et al. February 21, 2
2012-02-21
Polyalkylene Polymer Compounds And Uses Thereof
App 20120014916 - Lin; KoChung ;   et al.
2012-01-19
Composition Comprising Antibodies to LINGO or Fragments Thereof
App 20120014960 - MI; Sha ;   et al.
2012-01-19
Sp35 Antibodies and Uses Thereof
App 20110311542 - MI; SHA ;   et al.
2011-12-22
Composition comprising antibodies to LINGO or fragments thereof
Grant 8,058,406 - Mi , et al. November 15, 2
2011-11-15
Nogo receptor antagonists
Grant 8,030,456 - Lee , et al. October 4, 2
2011-10-04
Polyalkylene polymer compounds and uses thereof
Grant 8,017,733 - Lin , et al. September 13, 2
2011-09-13
Use of LINGO-4 Antagonists in the Treatment of Conditions Involving Demyelination
App 20110123553 - Mi; Sha ;   et al.
2011-05-26
Nogo receptor binding protein
Grant 7,785,829 - Mi , et al. August 31, 2
2010-08-31
NOGO Receptor Binding Protein
App 20100204304 - Mi; Sha ;   et al.
2010-08-12
Compositions And Methods For Administering Gdnf Ligand Family Proteins
App 20100056440 - Rossomando; Anthony ;   et al.
2010-03-04
Composition Comprising Antibodies to LINGO or Fragments Thereof
App 20100015131 - MI; Sha ;   et al.
2010-01-21
Sp35 Antibodies and Uses Thereof
App 20090252748 - MI; Sha ;   et al.
2009-10-08
NOGO Receptor Antagonists
App 20090215691 - Lee; Daniel H.S. ;   et al.
2009-08-27
Treatment of Conditions Involving Demyelination
App 20090175872 - Mi; Sha ;   et al.
2009-07-09
Oligodendrocyte-Myelin Glycoprotein Compositions and Methods of Use Thereof
App 20090175846 - Mi; Sha ;   et al.
2009-07-09
Nogo Receptor Antagonists
App 20090099078 - Lee; Daniel H.S. ;   et al.
2009-04-16
Nogo Receptor Polypeptides and Polypeptide Fragments and Uses Thereof
App 20090062199 - Wen; Dingyi ;   et al.
2009-03-05
Hydrophobically-modified protein compositions and methods
App 20090054632 - Pepinsky; R. Blake ;   et al.
2009-02-26
SP35 Antibodies and uses thereof
App 20090017039 - Mi; Sha ;   et al.
2009-01-15
Nogo receptor antagonists
Grant 7,465,705 - Lee , et al. December 16, 2
2008-12-16
Polymer Conjugates Of Mutated Neublastin
App 20080306212 - Sah; Dinah Wen-Yee ;   et al.
2008-12-11
Nogo Receptor Antagonists
App 20080274112 - Lee; Daniel H.S. ;   et al.
2008-11-06
Polymer conjugates of mutated neublastin
Grant 7,442,370 - Sah , et al. October 28, 2
2008-10-28
Refolding Transforming Growth Factor Beta Family Proteins
App 20080249287 - Rossomando; Anthony ;   et al.
2008-10-09
Neublastin Variants
App 20080039385 - Rossomando; Anthony ;   et al.
2008-02-14
Polymer-Conjugated Glycosylated Neublastin
App 20070238650 - Sah; Dinah Wen-Yee ;   et al.
2007-10-11
Cell adhesion inhibitors
Grant 7,196,112 - Lee , et al. March 27, 2
2007-03-27
Cell adhesion inhibitors
App 20070066533 - Lee; Wen-Cherng ;   et al.
2007-03-22
Nogo receptor binding protein
App 20070059793 - Mi; Sha ;   et al.
2007-03-15
Cell adhesion inhibitors
App 20060014966 - Lee; Wen-Cherng ;   et al.
2006-01-19
Treatment of conditions involving demyelination
App 20060009388 - Mi; Sha ;   et al.
2006-01-12
Nogo receptor antagonists
App 20050271655 - Lee, Daniel H.S. ;   et al.
2005-12-08
Polymer conjugates of mutated neublastin
App 20050142098 - Sah, Dinah Wen-Yee ;   et al.
2005-06-30
Hydrophobically-modified protein compositions and methods
App 20050119181 - Pepinsky, R. Blake ;   et al.
2005-06-02
Hydrophobically-modified protein compositions and methods
Grant 6,897,297 - Pepinsky , et al. May 24, 2
2005-05-24
Polyalkylene polymer compounds and uses thereof
App 20050107277 - Lin, KoChung ;   et al.
2005-05-19
Polymer conjugates of hedgehog proteins and uses
App 20040038876 - Pepinsky, R. Blake ;   et al.
2004-02-26
Functional antagonists of hedgehog activity
App 20030166543 - Williams, Kevin ;   et al.
2003-09-04
Hydrophobically-modified hedgehog protein compositions and methods
Grant 6,444,793 - Pepinsky , et al. September 3, 2
2002-09-03
Tat-derived transport polypeptides
Grant 6,316,003 - Frankel , et al. November 13, 2
2001-11-13
Muteins of IFN-.beta.
Grant 6,127,332 - Goelz , et al. October 3, 2
2000-10-03
Tat-derived transport polypeptides and fusion proteins
Grant 5,804,604 - Frankel , et al. September 8, 1
1998-09-08
Tat-derived transport polypeptide conjugates
Grant 5,747,641 - Frankel , et al. May 5, 1
1998-05-05
Fusion protein comprising tat-derived transport moiety
Grant 5,674,980 - Frankel , et al. October 7, 1
1997-10-07
Nucleic acid conjugates of tat-derived transport polypeptides
Grant 5,670,617 - Frankel , et al. September 23, 1
1997-09-23
Nucleic acids encoding and methods of making tat-derived transport polypeptides
Grant 5,652,122 - Frankel , et al. July 29, 1
1997-07-29
Muteins of IFN-.beta.
Grant 5,545,723 - Goelz , et al. August 13, 1
1996-08-13
DNA sequences, recombinant DNA molecules and processes for producing lipocortin-like polypeptides
Grant 5,081,019 - Wallner , et al. January 14, 1
1992-01-14
DNA sequences, recombinant DNA molecules and processes for producing human phospholipase inhibitor polypeptides
Grant 4,879,224 - Wallner , et al. November 7, 1
1989-11-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed